• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • SMC endorses EUSA Pharma’s Qarziba pharmatimes
    November 14, 2018
    A medicine used to treat a rare cancer that predominantly occurs in very young children is to be routinely funded on the NHS in Scotland.
  • EUSA Pharma’s tivozanib drug approved for kidney cancer in Scotland pharmaceutical-technology
    July 12, 2018
    Scotland’s pharmaceutical regulatory authority the Scottish Medicines Consortium (SMC) has recommended Jazz Pharmaceutical spin-off EUSA Pharma’s fotivda (tivozanib) for the first line treatment of adults with advanced renal cell carcinoma (RCC).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service